Stay up to date with notifications from The Independent

Notifications can be managed in browser preferences.

Japan's Kirin to sell China joint venture to investment fund

Kirin is selling its China joint venture to an investment fund, shortly after the Japanese beer and beverage maker decided to pull out of Myanmar, where it had a beer brewery

Via AP news wire
Wednesday 16 February 2022 05:18 GMT
Japan Kirin China
Japan Kirin China (Copyright 2020 The Associated Press. All rights reserved.)

Your support helps us to tell the story

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or producing our latest documentary, 'The A Word', which shines a light on the American women fighting for reproductive rights, we know how important it is to parse out the facts from the messaging.

At such a critical moment in US history, we need reporters on the ground. Your donation allows us to keep sending journalists to speak to both sides of the story.

The Independent is trusted by Americans across the entire political spectrum. And unlike many other quality news outlets, we choose not to lock Americans out of our reporting and analysis with paywalls. We believe quality journalism should be available to everyone, paid for by those who can afford it.

Your support makes all the difference.

Kirin is selling its China soft drinks joint venture to an investment fund, the Japanese beer and beverage maker said Wednesday.

The move comes shortly after Kirin decided to pull out of a joint venture brewery in Myanmar.

The sale to Plateau Consumer, a Chinese fund, for 115 billion yen ($994 million) covers Kirin’s entire 40% stake in China Resources Kirin Beverages, Tokyo-based Kirin said in a statement.

The joint venture, established in 2011, had been expanding its business in China, making bottled water and bottled tea, according to Kirin Holdings Co.

Kirin said the move was part of its recent decision to review its investment portfolio, including foreign operations, under a management plan that runs through 2024.

The plan has the company focusing on certain areas, including pharmaceuticals and health science as well as food and beverages.

More recently, Kirin has been trying to streamline its sprawling operations to focus on projects like developing drugs for diseases that have no existing treatments, and working on what Kirin calls LC-Plasma to offer health products that help maintain immune systems.

Kirin is among Japan’s top beer brands, but beer companies here have in recent decades expanded into other kinds of beverages. It still has various global operations, including Four Roses Distillery in the U.S. and San Miguel Brewery in the Philippines.

___

Yuri Kageyama is on Twitter https://twitter.com/yurikageyama

Thank you for registering

Please refresh the page or navigate to another page on the site to be automatically logged inPlease refresh your browser to be logged in